Femasys Inc. (NASDAQ:FEMY) Financings

Femasys Inc.

Financings

RaiseDate
Private placement of common stock and pre-funded warrants with accompanying warrants
Closed: US$30M raised · US$3.2 a share · Warrants at US$2.95 for 36 months · Laidlaw & Company (UK) Ltd. +1
Dealers: Laidlaw & Company (UK) Ltd. (lead), Lake Street Capital Markets, LLC
Buyers: Nantahala Capital (Led the financing as new institutional investor); Rosalind Advisors, Inc.
Insiders: Members of Femasys' management team participated.
Use of proceeds: Support strategic priorities: executing commercial initiatives, advancing clinical programs and key operational objectives
Aug 14, 2026
Public offering of financing
Closed: US$8M raised · US$0.36 a share · Warrants at US$0.36 for 60 months · Jones +1
Dealers: Jones (co-lead), Laidlaw & Company (UK) Ltd. (co-lead)
Buyers: Jorey Chernett
Insiders: Certain officers bought 87,363 shares and accompanying warrants at $0.5151 per share and accompanying warrant
Use of proceeds: To accelerate commercialization efforts for its FemaSeed and FemBloc fertility and birth control products
Sep 2, 2025
Public offering of common stock
Announced: US$0.85 a share · Jones
Dealers: Jones (lead)
Use of proceeds: Expansion of commercial efforts, product development, general corporate purposes, capital expenditures, working capital and G&A expenses
May 30, 2025
Private placement of common stock
Announced: US$0.85 a share · Jones
Dealers: Jones (lead)
Insiders: Certain directors and officers buy at a price of $1.02 per share
Use of proceeds: Expansion of commercial efforts, product development, general corporate purposes, capital expenditures, working capital and G&A expenses
May 30, 2025

Read by 6ix AI from the company's releases